3B Pharmaceuticals Gmbh company information, Employees & Contact Information

Merck grows again in Va. with $3B small-molecule drug plant, part of planned $70B US outlay Fierce Pharma

Merck Begins Construction of $3B Manufacturing Facility in VA Contract Pharma

ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors PR Newswire

ASCO25: Actuate flexes survival benefit of front-line elraglusib in mid-stage pancreatic cancer study FirstWord Pharma

Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 Fierce Pharma

RefleXion acquires radiopharmaceutical rights from 3B Pharmaceuticals AuntMinnie

Novartis in US$465m deal with 3B Pharmaceuticals GmbH European Biotechnology Magazine

3BP, Novartis enter into deal for FAP-targeting peptide technology Pharmaceutical Technology

Novartis pens $425M biobucks deal with German biotech, scooping up more radiopharmaceutical tech Fierce Biotech

Merck will lay off 6,000, reducing workforce by 8% in cost-cutting purge Fierce Pharma

Bristol makes its radiopharma move | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Novartis strikes $425M deal with 3BP for FAP-targeting peptide technology Medical Marketing and Media

Amid industry's onshoring push, Regeneron taps Fujifilm Diosynth for $3B, 10-year commercial manufacturing team-up Fierce Pharma

Clovis offloads targeted radionuclide therapy to Novartis, files for bankruptcy FirstWord Pharma

At odds with largest shareholder, Bavarian Nordic agrees to $3B buyout by Nordic and Permira Fierce Pharma

Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal Fierce Pharma

On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin Fierce Pharma

Novo Nordisk expands Ozempic's turf with new FDA nod to curb kidney disease risks Fierce Pharma

In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's Darzalex Fierce Pharma

From market withdrawal back to £3B peak sales: GSK dreams big for myeloma ADC Blenrep Fierce Pharma

Amgen Invests $3B to Expand Mfg. Facility in North Carolina Contract Pharma

BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says Fierce Pharma

Bayer hikes Nubeqa's peak sales to more than €3B on prostate cancer data, teeing up new 3-way battle against Pfizer-Astellas, J&J Fierce Pharma

Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS Fierce Pharma

Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks Fierce Biotech

Quarterly sales of Sanofi’s Dupixent cross €3B for the first time FirstWord Pharma

Eli Lilly lifts sales guidance by $3B as supplies of Mounjaro and Zepbound recover Fierce Pharma

Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe Fierce Pharma

JPM23: Bayer hikes sales targets for Kerendia, Nubeqa to $3B each Fierce Pharma

AstraZeneca touts 'overwhelming' Tagrisso win among 3 lung cancer portfolio advancements Fierce Pharma

Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? Fierce Pharma

Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms Fierce Pharma

Viatris weighs $3B sale of European consumer drugs amid larger $9B offloading effort: Bloomberg Fierce Pharma

Bristol Myers joins AstraZeneca, Merck in touting positive lung cancer drug use around surgery Fierce Pharma

ESMO: AZ, Daiichi build case for Enhertu in breast cancer patients with brain metastases Fierce Pharma

Concordia reports $1.3B loss after taking $1.1B write-off on pressured generics Fierce Pharma

AstraZeneca's Tagrisso, aiming for $3B in sales, trounces chemo in new phase 3 trial Fierce Pharma

Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive Fierce Pharma

Roche wraps up $4.3B Spark buyout as FTC thumbs-up ends antitrust ordeal Fierce Pharma

Eli Lilly's Kisunla wins FDA nod for new dosing with fewer side effects in Alzheimer's Fierce Pharma

UroGen Pharma Announces Publication of Phase 3b Study on At-Home Administration of ZUSDURI™ for Bladder Cancer Treatment Quiver Quantitative

With its €5.3B buyout scuppered, Stada brings in new CEO, CFO Fierce Pharma

ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients Fierce Pharma

Samsung buys Biogen out of biosimilar unit for $2.3B—not the whole Aduhelm headache Fierce Pharma

Top 20 biotech startups raise $2.9B in Q1 2024 funding surge drugdiscoverytrends.com

Radiopharmaceutical company Convergent closes series A to the tune of $90M Fierce Biotech

Fresenius' $4.3B buyout of Akorn threatened by data integrity probe Fierce Pharma

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy Fierce Pharma

AAD: AbbVie's Skyrizi clears psoriasis symptoms where Novartis' Cosentyx, Lilly's Taltz couldn't Fierce Pharma

AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis Fierce Pharma

PAREXEL Names New CEO Contract Pharma

Best way for Teva to deal with Copaxone threat? Settle, analyst urges Fierce Pharma

Roche sees glimmer of hope for $4.3B Spark deal as FTC staff gives thumbs-up: report Fierce Pharma

Roche forced to extend Spark tender offer as investors sue over $4.3B merger Fierce Pharma

Alphabet’s Isomorphic stacks two new deals with Lilly, Novartis worth nearly $3B ahead of JPM Fierce Biotech

AstraZeneca's Fasenra spares asthma patients from steroid use in large trial Fierce Pharma

Novo Nordisk, following in Lilly's Trulicity footsteps, files higher Ozempic dose for diabetes Fierce Pharma

Sanofi, Regeneron ready to roll with $3B-plus Dupixent approval Fierce Pharma

Citi Pharma attracts Rs2.3b in IPO The Express Tribune

Europe’s shot at radiopharmaceutical leadership VC Magazin

Kanyama gets his way with N$1,3b pharma tender The Namibian -